MedPath

Efficacy of Clinacanthus nutans Lindau cream comparing with podophyllin for treating anogenital warts among Thai males: A self-comparison, randomized controlled trial

Phase 1
Recruiting
Conditions
anogenital wart
podophyllin
clinacanthus nutans lindau cream
Registration Number
TCTR20170621003
Lead Sponsor
Siriraj hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
12
Inclusion Criteria

1. male patients 18 years and older
2. diagnosed as anogenitalwart
3. at least two lesions of wart which are at least 1 cm apart
4. consent form obtained

Exclusion Criteria

1. patients with HIV infection
2. patients on immunosuppressive drugs
3. patients with autoimmune disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
size reduction of anogenital wart 4 week quantitative measurement(mm)
Secondary Outcome Measures
NameTimeMethod
viral loads of genital wart 4 week quantitative measurement(digital droplet PCR- Each droplet represents as 1 HPV DNA copy),gene expression of genital wart 4 week qualitative measurement(Nanostring technology- number of gene for log fold change compare to houseke,side effects of clinacanthus nutans lindau cream 4 week qualitative measurement(clinical symptoms- erythema, ulceration)
© Copyright 2025. All Rights Reserved by MedPath